Through an analysis of genomic mutations, mutations in TP53 (55.26%), KEAP1 (40.75%), STK11 (37.92%) and KRAS (36.54%) exhibited the highest co‐occurrence rates with SMARCA4 mutations among the commonly mutant genes in lung cancer. This evidence concerns the gene STK11 and lung carcinoma.